Tumor necrosis factor beta gene polymorphisms in Graves' disease

Area of Science:

• Immunogenetics
• Molecular Biology
• Human Genetics

Background:

• The short arm of chromosome 6 contains genes for tumor necrosis factor alpha (TNF alpha) and lymphotoxin (TNF beta).
• This region is crucial for immune responses and harbors susceptibility genes for autoimmune disorders, particularly those linked to HLA D subregion alleles.
• A TNF restriction fragment length polymorphism (RFLP) using NcoI was previously identified.

Purpose of the Study:

• To investigate the association between TNF gene polymorphisms and Graves' disease.
• To determine if TNF beta polymorphisms are independent risk factors for Graves' disease, beyond their linkage with the HLA A1B8DR3 haplotype.

Main Methods:

• Analysis of TNF gene polymorphisms (specifically NcoI RFLP) in a large cohort of Graves' disease patients and healthy controls from four centers.
• Statistical analysis, including chi-squared tests, to compare allele and genotype frequencies between patient and control groups.
• Subgroup analysis of DR3-positive patients and controls, and analysis of patients with TSH-receptor antibodies.

Main Results:

• A significant association was found between TNF beta gene polymorphisms and Graves' disease.
• Graves' disease patients exhibited fewer homozygotes (10.5 kb band) and more heterozygotes (10.5/5.5 kb) for TNF beta gene fragments compared to controls.
• This association remained significant even when analyzing DR3-positive individuals separately.
• TNF beta heterozygosity was more prevalent in Graves' disease patients with TSH-receptor antibodies, suggesting an immunogenetic subset.

Conclusions:

• TNF beta gene polymorphisms represent an additional susceptibility marker for Graves' disease.
• The findings suggest that TNF beta variations contribute to the genetic predisposition to Graves' disease, potentially identifying a specific immunogenetic subset of patients.